The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. After-hours trades for Evolus Inc (EOLS) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by $1.26, or 15.59%, to $9.34. The Evolus Inc has recorded 604,517 volume in the after hours trading session. Most recently, Yahoo Finance reported about the stock as it publicized that Evolus Reports Record Third Quarter 2023 Financial Results and Phase II Data for Extra-Strength 40U Formulation of Jeuveau®.
Evolus Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Drug Manufacturers – Specialty & Generic industry. At the end of the last regular session, the stock closed at $8.08 and fluctuated between $8.20 as its day high and $7.89 as its day low. The current market capitalization of Evolus Inc is $460.32M. A total of 0.71 million shares were traded on the day, compared to an average of 502.51K shares.
Additionally, investors take into account insider trades when predicting how a stock will perform. During the recent three months, EOLS has seen 10 BUY and 4 SELL insider trades, representing the acquisition of 508,369 and the disposition of 22,378 shares. Over the last 12 months, there were 20 BUYs and 10 SELLs from insiders. Insiders purchased 914,631 shares during that period but sold 4,182,159.
In the most recent transaction, Medytox Inc. sold 1,690,663 shares of EOLS for 7.50 per share on Oct 16. After the transaction, the Former 10% Owner now owns 3,381,326 company shares. In a previous transaction on Sep 06, Beaver Sandra sold 3,178 shares at 9.70 per share. EOLS shares that Chief Financial Officer owns now total 113,368.
Among the insiders who sold shares, MOATAZEDI DAVID disposed of 14,778 shares on Aug 16 at a per-share price of $10.27. This resulted in the insider holding 686,592 shares of EOLS after the transaction. In another insider transaction, Avelar Rui sold 2,211 shares at $10.27 per share on Aug 16. Company shares held by the insider now total 353,386.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. According to analysts who have offered 12-month price targets for EOLS in the last 3 months, the mean price target is $20.25 with high estimates of $27.00 and low estimates of $10.00. In terms of 52-week highs and lows, EOLS has a high of $11.49 and a low of $6.51.
As of this writing, EOLS has an earnings estimate of -$0.17 per share for the current quarter. EPS was calculated based on a consensus of 5 estimates, with a high estimate of -$0.12 per share and a lower estimate of -$0.24.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. EOLS’s latest balance sheet shows that the firm has $146.26M in Cash & Short Term Investments as of fiscal 2021. There were $74.74M in debt and $57.66M in liabilities at the time. Its Book Value Per Share was -$0.12, while its Total Shareholder’s Equity was $81.88M.
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for EOLS is Buy with a score of 4.80.